Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-042813
Filing Date
2017-12-07
Accepted
2017-12-07 12:18:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33418
  Complete submission text file 0000000000-17-042813.txt   46772
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filed for) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations